Literature DB >> 28054137

[Local treatment of solitary intrapulmonary, malignant nodules].

J Op den Winkel1, F Eichhorn1, S Rieken2, H Dienemann3,4.   

Abstract

DEFINITION: Intrapulmonary nodules generally represent an incidental finding in the roentgenogram or computed tomography (CT) scan of the chest. They are defined as single, well-circumscribed, radiographic opaque lesions that measures up to 3 cm in diameter and are surrounded completely by aerated lung. The probability of malignancy directly correlates with increasing diameter. Lesions that have a diameter of 1 cm or larger require direct evaluation. THERAPY: Surgery is the first option for patients with a malignant lesion, given an acceptable perioperative risk; for high-risk patients either radiofrequency ablation (RFA) or stereotactic body radiation therapy (SBRT) should be offered. In these cases the malignant histology has to be established beforehand or verified by radiologic proven growth. OUTCOME: Complete surgical resection is superior to RFA and SBRT with respect to local tumor control.

Entities:  

Keywords:  Cancer of the lung; Catheter ablation; Pulmonary coin lesion; Stereotactic body radiotherapy; Surgery

Mesh:

Year:  2017        PMID: 28054137     DOI: 10.1007/s00117-016-0200-0

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  31 in total

1.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

Review 2.  Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?

Authors:  Stéphane Renaud; Pierre-Emmanuel Falcoz; Anne Olland; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-10

3.  Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.

Authors:  Eva M Bongers; Cornelis J A Haasbeek; Frank J Lagerwaard; Ben J Slotman; Suresh Senan
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

4.  Pulmonary radiofrequency ablation in a district general hospital: is it a safe and effective treatment?

Authors:  S L Smith; D Bowers; P Jennings; R Soomal
Journal:  Clin Radiol       Date:  2016-05-04       Impact factor: 2.350

5.  [High-dose, stereotactic, one-time radiotherapy with curative intent for peripheral lung cancer].

Authors:  B Wahlers; J Debus; S Dröge; B Brendle; L Freitag
Journal:  Pneumologie       Date:  2000-11

6.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

Review 7.  Minimally invasive resection of early lung cancers.

Authors:  Aaron M Cheng; Douglas E Wood
Journal:  Oncology (Williston Park)       Date:  2015-03       Impact factor: 2.990

8.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Authors:  Inga S Grills; Victor S Mangona; Robert Welsh; Gary Chmielewski; Erika McInerney; Shannon Martin; Jennifer Wloch; Hong Ye; Larry L Kestin
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

9.  Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.

Authors:  S Lafuente; D Fuster; P Arguis; U Granados; P Perlaza; P Paredes; I Vollmer; M Sánchez; F Lomeña
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2016-02-02       Impact factor: 1.359

10.  Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.

Authors:  M Guckenberger; N Andratschke; H Alheit; R Holy; C Moustakis; U Nestle; O Sauer
Journal:  Strahlenther Onkol       Date:  2013-09-21       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.